Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Pfizer's phase III axitinib trial in renal cell carcinoma meets primary endpoint

Dec. 1, 2010

Immunovaccine and OncoTherapy Science join to develop cancer vaccine

Dec. 1, 2010

Multikinase inhibitor AI-1008 shows promise to treat chronic myeloid leukemia in preclinical testing

Dec. 1, 2010

GlaxoSmithKline claims new inhibitors of focal adhesion kinase 1

Dec. 1, 2010

Preclinical activity of LY-S6KAKT1 justifies entry into phase I trial as cancer therapy

Dec. 1, 2010

FDA to review Spectrum Pharma's complete response regarding Fusilev sNDA

Nov. 30, 2010

New inhibitors of cell division protein kinase 4 claimed

Nov. 30, 2010

New inhibitors of dual specificity protein kinase TTK patented

Nov. 30, 2010

CXR-1002 shows promising safety and antitumor activity in first-in-human trial in advanced cancer

Nov. 30, 2010

New apoptosis-inducing molecules discovered

Nov. 30, 2010

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...